In the past few weeks, I have been involved in two publications in the field of disability sports medicine that have been accepted for publication. The first is in Clinical Journal of Sport Medicine, and explored the differences in baseline concussion scores between athletes with and without disability (http://journals.lww.com/cjsportsmed/Abstract/publishahead/Do_Neurocognitive_SCAT3_Baseline_Test_Scores.99486.aspx). This study demonstrated that traditional ways of testing for concussion in athletes that already have a disability are flawed, and is part of a larger PhD study which is evaluating this area.
The second study (which is not yet available online) was accepted by the journal “PM&R”, and is titled “Medication and supplement use in disability football world championships”. This builds on the work of one of the co-authors on this (Phillipe Tscholl), who has conducted extensive research into the overprescription of medications in elite sport (http://bmjopen.bmj.com/content/5/9/e007608). Findings from our study were consistent with previous work in the area, and indicated that there were very high rates of prescribing anti-inflammatory medications.
Osman Ahmed, Faculty of Health and Social Sciences
Four new FHSS publications
Nature, nurture & beyond: what underpins exceptional sport performance?










3C Event: Research Culture, Community & Cherry Blossom
Boost Your Research Profile: Training Sessions with The Conversation
ESRC Festival of Social Science 2026: An Opportunity to Engage New Audiences
New HIV paper by BU PhD student
BU Annual Research Conference: Poster Exhibition Call for Applications
Vitae Three Minute Thesis (3MT®) Competition: Applications Now Open
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease